Search

Scott Long

Examiner (ID: 7374, Phone: (571)272-9048 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1633
Total Applications
882
Issued Applications
557
Pending Applications
29
Abandoned Applications
301

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5247286 [patent_doc_number] => 20070243520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Method for screening an agent for preventing or ameliorating wrinkles' [patent_app_type] => utility [patent_app_number] => 11/405471 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5035 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243520.pdf [firstpage_image] =>[orig_patent_app_number] => 11405471 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/405471
Method for screening an agent for preventing or ameliorating wrinkles Apr 17, 2006 Issued
Array ( [id] => 5252805 [patent_doc_number] => 20070134261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Effectors of innate immunity' [patent_app_type] => utility [patent_app_number] => 11/400411 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 117567 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134261.pdf [firstpage_image] =>[orig_patent_app_number] => 11400411 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/400411
Effectors of innate immunity Apr 6, 2006 Abandoned
Array ( [id] => 5687718 [patent_doc_number] => 20060286033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Targeting pulmonary epithelium using ADRP' [patent_app_type] => utility [patent_app_number] => 11/397320 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17502 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286033.pdf [firstpage_image] =>[orig_patent_app_number] => 11397320 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/397320
Targeting pulmonary epithelium using ADRP Apr 2, 2006 Issued
Array ( [id] => 5851719 [patent_doc_number] => 20060234910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Methods for the treatment of insulin resistance and disease states characterized by insulin resistance' [patent_app_type] => utility [patent_app_number] => 11/388155 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10533 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234910.pdf [firstpage_image] =>[orig_patent_app_number] => 11388155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/388155
Methods for the treatment of insulin resistance and disease states characterized by insulin resistance Mar 22, 2006 Abandoned
Array ( [id] => 5278627 [patent_doc_number] => 20090130759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Culture Medium Containing Kinase Inhibitor, and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/909545 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4329 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130759.pdf [firstpage_image] =>[orig_patent_app_number] => 11909545 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909545
Culture Medium Containing Kinase Inhibitor, and Use Thereof Mar 21, 2006 Abandoned
Array ( [id] => 5888678 [patent_doc_number] => 20060275797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders' [patent_app_type] => utility [patent_app_number] => 11/384638 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5492 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275797.pdf [firstpage_image] =>[orig_patent_app_number] => 11384638 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/384638
Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders Mar 19, 2006 Abandoned
Array ( [id] => 5759599 [patent_doc_number] => 20060210544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient' [patent_app_type] => utility [patent_app_number] => 11/377610 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 38026 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210544.pdf [firstpage_image] =>[orig_patent_app_number] => 11377610 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377610
Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient Mar 16, 2006 Abandoned
Array ( [id] => 4979384 [patent_doc_number] => 20070220619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Methods for testing for caloric restriction (CR) mimetics' [patent_app_type] => utility [patent_app_number] => 11/377986 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 5367 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20070220619.pdf [firstpage_image] =>[orig_patent_app_number] => 11377986 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377986
Methods for testing for caloric restriction (CR) mimetics Mar 16, 2006 Issued
Array ( [id] => 62963 [patent_doc_number] => 07758855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'DNA promoters and anthrax vaccines' [patent_app_type] => utility [patent_app_number] => 11/378003 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 50 [patent_no_of_words] => 12951 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/758/07758855.pdf [firstpage_image] =>[orig_patent_app_number] => 11378003 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378003
DNA promoters and anthrax vaccines Mar 16, 2006 Issued
Array ( [id] => 5760144 [patent_doc_number] => 20060211089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Expression of defensins in filamentous fungi' [patent_app_type] => utility [patent_app_number] => 11/377883 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13033 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211089.pdf [firstpage_image] =>[orig_patent_app_number] => 11377883 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377883
Expression of defensins in filamentous fungi Mar 14, 2006 Abandoned
Array ( [id] => 5148805 [patent_doc_number] => 20070048865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Method for acceleration of stem cell differentiation' [patent_app_type] => utility [patent_app_number] => 11/377847 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2747 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048865.pdf [firstpage_image] =>[orig_patent_app_number] => 11377847 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377847
Method for acceleration of stem cell differentiation Mar 14, 2006 Abandoned
Array ( [id] => 5135980 [patent_doc_number] => 20070077609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/373679 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26915 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077609.pdf [firstpage_image] =>[orig_patent_app_number] => 11373679 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/373679
Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof Mar 9, 2006 Issued
Array ( [id] => 5734872 [patent_doc_number] => 20060259989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Sporadic tumor mouse model for drug discovery' [patent_app_type] => utility [patent_app_number] => 11/371825 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6605 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20060259989.pdf [firstpage_image] =>[orig_patent_app_number] => 11371825 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/371825
Sporadic tumor mouse model for drug discovery Mar 8, 2006 Abandoned
Array ( [id] => 5610523 [patent_doc_number] => 20060272039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Methods of identifying longevity modulators and therapeutic methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/372469 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26076 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20060272039.pdf [firstpage_image] =>[orig_patent_app_number] => 11372469 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372469
Methods of identifying longevity modulators and therapeutic methods of use thereof Mar 7, 2006 Issued
Array ( [id] => 5699592 [patent_doc_number] => 20060216276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Use of materials for treatment of central nervous system lesions' [patent_app_type] => utility [patent_app_number] => 11/368919 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21757 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216276.pdf [firstpage_image] =>[orig_patent_app_number] => 11368919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/368919
Use of materials for treatment of central nervous system lesions Mar 5, 2006 Abandoned
Array ( [id] => 5786576 [patent_doc_number] => 20060205704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Modulation of neurodegenerative diseases through the progesterone receptor' [patent_app_type] => utility [patent_app_number] => 11/365962 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10142 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205704.pdf [firstpage_image] =>[orig_patent_app_number] => 11365962 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365962
Modulation of neurodegenerative diseases through the progesterone receptor Feb 28, 2006 Abandoned
Array ( [id] => 7795368 [patent_doc_number] => 08124074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/792076 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12516 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124074.pdf [firstpage_image] =>[orig_patent_app_number] => 11792076 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792076
Fusion proteins Nov 30, 2005 Issued
Array ( [id] => 5866238 [patent_doc_number] => 20060100369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Bifunctional-modified hydrogels' [patent_app_type] => utility [patent_app_number] => 11/273393 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19635 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100369.pdf [firstpage_image] =>[orig_patent_app_number] => 11273393 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273393
Bifunctional-modified hydrogels Nov 13, 2005 Abandoned
Array ( [id] => 4886901 [patent_doc_number] => 20080261233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf)' [patent_app_type] => utility [patent_app_number] => 11/665893 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5943 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261233.pdf [firstpage_image] =>[orig_patent_app_number] => 11665893 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665893
Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf) Oct 19, 2005 Abandoned
Array ( [id] => 5917839 [patent_doc_number] => 20060130161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes' [patent_app_type] => utility [patent_app_number] => 11/248499 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23234 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20060130161.pdf [firstpage_image] =>[orig_patent_app_number] => 11248499 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/248499
Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes Oct 11, 2005 Abandoned
Menu